Comparison of respiratory medications
| β-Blocker | |||
|---|---|---|---|
| Yes (n=474) | No (n=2990) | p Value | |
| SABA, % | 264 (56.8) | 1791 (60.7) | 0.105 |
| SAMA, % | 65 (14.3) | 598 (20.6) | 0.002 |
| LABA*, % | 188 (39.7) | 1433 (47.9) | 0.001 |
| LAMA, % | 174 (37.6) | 1166 (40.1) | 0.297 |
| ICS*, % | 191 (40.3) | 1494 (50.0) | <0.001 |
| Combination ICS/LABA, % | 173 (37.9) | 1324 (46.2) | 0.001 |
| Triple therapy, % | 102 (22.4) | 814 (28.4) | 0.008 |
| Theophylline, % | 9 (2.3) | 138 (4.7) | 0.027 |
| Systemic steroids, % | 11 (2.8) | 178 (6.1) | 0.008 |
*This medication was used alone or in combination.
ICS, inhaled corticosteroid; LABA, long-acting β-agonist; LAMA, long-acting muscarinic antagonist; SABA, short-acting β-agonist; SAMA, short-acting muscarinic antagonist; Triple therapy, ICS+LABA+LAMA.